681 related articles for article (PubMed ID: 11586215)
1. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
2. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
[TBL] [Abstract][Full Text] [Related]
3. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of short-term retrievable ureteral stent in pediatric laparoscopic pyeloplasty.
Yucel S; Samuelson ML; Nguyen MT; Baker LA
J Urol; 2007 Feb; 177(2):720-5; discussion 725. PubMed ID: 17222666
[TBL] [Abstract][Full Text] [Related]
5. Retrograde stenting for obstruction of the renal transplant ureter.
Gerrard ER; Burns JR; Young CJ; Urban DA; Hammontree LN; El-Galley R; Kolettis PN
Urology; 2005 Aug; 66(2):256-60; discussion 260. PubMed ID: 16098351
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
7. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
8. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
9. [Endoscopic management of bilateral ureteral obstruction after radiotherapy].
Zeng GH; Li X; Wu KJ; Chen WZ
Ai Zheng; 2004 Jan; 23(1):108-9. PubMed ID: 14720387
[TBL] [Abstract][Full Text] [Related]
10. Ureteral obstruction: is the full metallic double-pigtail stent the way to go?
Liatsikos E; Kallidonis P; Kyriazis I; Constantinidis C; Hendlin K; Stolzenburg JU; Karnabatidis D; Siablis D
Eur Urol; 2010 Mar; 57(3):480-6. PubMed ID: 19232816
[TBL] [Abstract][Full Text] [Related]
11. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.
Kamiyama Y; Matsuura S; Kato M; Abe Y; Takyu S; Yoshikawa K; Arai Y
Int J Urol; 2011 May; 18(5):379-82. PubMed ID: 21518020
[TBL] [Abstract][Full Text] [Related]
12. Serum creatinine predicts success in retrograde ureteral stent placement in patients with pelvic malignancies.
McCullough TC; May NR; Metro MJ; Ginsberg PC; Jaffe JS; Harkaway RC
Urology; 2008 Aug; 72(2):370-3. PubMed ID: 18336878
[TBL] [Abstract][Full Text] [Related]
13. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi.
Pearle MS; Pierce HL; Miller GL; Summa JA; Mutz JM; Petty BA; Roehrborn CG; Kryger JV; Nakada SY
J Urol; 1998 Oct; 160(4):1260-4. PubMed ID: 9751331
[TBL] [Abstract][Full Text] [Related]
14. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction.
Mertens S; Zeegers AG; Wertheimer PA; Hendriksz TR; van Bommel EF
Int J Urol; 2014 Mar; 21(3):283-8. PubMed ID: 24033464
[TBL] [Abstract][Full Text] [Related]
17. Endourological management of ureteral obstruction after renal transplantation.
Bosma RJ; van Driel MF; van Son WJ; de Ruiter AJ; Mensink HJ
J Urol; 1996 Sep; 156(3):1099-100. PubMed ID: 8709316
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for recurrent ureteropelvic junction obstruction after open pyeloplasty in a large pediatric cohort.
Braga LH; Lorenzo AJ; Bägli DJ; Keays M; Farhat WA; Khoury AE; Salle JL
J Urol; 2008 Oct; 180(4 Suppl):1684-7; discussion 1687-8. PubMed ID: 18708226
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
20. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.
Jeong IG; Han KS; Joung JY; Seo HK; Chung J
BJU Int; 2007 Dec; 100(6):1288-91. PubMed ID: 17850371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
